(RPRX) Royalty Pharma - Performance 22.1% in 12m
Compare RPRX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-23.28%
#78 in Group
Rel. Strength
76.70%
#1860 in Universe
Total Return 12m
22.10%
#38 in Group
Total Return 5y
-18.11%
#76 in Group
P/E 17.1
26th Percentile in Group
P/E Forward 10.5
33th Percentile in Group
PEG 2.28
80th Percentile in Group
FCF Yield 11.3%
(?) Percentile in Group
12m Total Return: RPRX (22.1%) vs XLV (1.7%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-37.1% | 208% | 466% | 57.7 | 43.5 | 0.61 | 55.9% | 3.42% |
| LLY NYSE Eli Lilly |
8.84% | 15.8% | 523% | 75.7 | 38.9 | 1.41 | 41.1% | 48.6% |
| NVS NYSE Novartis |
1.8% | 21.1% | 74.9% | 19.2 | 13.7 | 1.3 | 35.8% | 4.22% |
| SFZN SW Siegfried Holding |
8.63% | 12.1% | 131% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
| NOVN SW Novartis |
-4.14% | 9.09% | 50% | 19.2 | 13.5 | 1.29 | 35.8% | 3.8% |
| SOBI ST Swedish Orphan Biovitrum |
1.95% | 2.66% | 56.9% | 24.7 | 20.6 | 1.59 | 7.30% | 30.4% |
| SAN PA Sanofi |
-5.91% | 7.31% | 26.6% | 18.5 | 11.2 | 0.9 | -20.4% | 16.2% |
| SUPN NASDAQ Supernus Pharmaceuticals |
-0.82% | 7.91% | 46.7% | 24.4 | 20.2 | 1.47 | -13.6% | -12.5% |
Performance Comparison: RPRX vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for RPRX
| Total Return (including Dividends) | RPRX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 5.43% | -3.79% | -0.87% |
| 3 Months | 4.62% | -3.99% | -7.58% |
| 12 Months | 22.10% | 1.72% | 11.88% |
| 5 Years | -18.11% | 55.40% | 110.33% |
| Trend Score (consistency of price movement) | RPRX | XLV | S&P 500 |
| 1 Month | 72.3% | -3.2% | 23% |
| 3 Months | -4.50% | -71.4% | -88.5% |
| 12 Months | 53.9% | -17.5% | 55.1% |
| 5 Years | -78.2% | 89.8% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #65 | 9.59% | 6.35% |
| 3 Month | #42 | 8.96% | 13.2% |
| 12 Month | #37 | 20.0% | 9.13% |
| 5 Years | #77 | -46.0% | -57.0% |
FAQs
Does RPRX Royalty Pharma outperforms the market?
Yes,
over the last 12 months RPRX made 22.10%, while its related Sector, the Health Care Sector SPDR (XLV) made 1.72%.
Over the last 3 months RPRX made 4.62%, while XLV made -3.99%.
Over the last 3 months RPRX made 4.62%, while XLV made -3.99%.
Performance Comparison RPRX vs Indeces and Sectors
RPRX vs. Indices RPRX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | - | 6.30% | 25.2% | 10.2% |
| US NASDAQ 100 | QQQ | -1.03% | 4.03% | 24.8% | 9.43% |
| US Dow Jones Industrial 30 | DIA | 0.94% | 8.61% | 25.3% | 12.9% |
| German DAX 40 | DAX | 1.23% | 4.11% | 5.72% | -2.58% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.96% | 8.25% | 28.2% | 16.1% |
| Hongkong Hang Seng | HSI | 0.99% | 5.37% | 23.3% | 8.21% |
| India NIFTY 50 | INDA | 2.84% | 1.37% | 25.0% | 19.0% |
| Brasil Bovespa | EWZ | 0.80% | 0.83% | 21.5% | 27.9% |
RPRX vs. Sectors RPRX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.25% | 6.48% | 19.1% | -1.86% |
| Consumer Discretionary | XLY | -0.08% | 5.53% | 22.7% | 8.78% |
| Consumer Staples | XLP | 3.50% | 5.23% | 19.9% | 10.9% |
| Energy | XLE | 4.48% | 19.3% | 31.0% | 33.2% |
| Financial | XLF | 1.39% | 7.54% | 17.6% | -0.59% |
| Health Care | XLV | 0.08% | 9.22% | 26.9% | 20.4% |
| Industrial | XLI | -0.42% | 5.32% | 24.5% | 12.5% |
| Materials | XLB | 0.61% | 7.86% | 32.7% | 25.6% |
| Real Estate | XLRE | 1.52% | 6.74% | 26.1% | 4.01% |
| Technology | XLK | -2.45% | 3.74% | 28.6% | 14.4% |
| Utilities | XLU | 2.84% | 5.37% | 23.1% | 0.27% |
| Aerospace & Defense | XAR | -0.95% | -0.96% | 11.7% | -4.47% |
| Biotech | XBI | -1.30% | 3.15% | 37.9% | 23.9% |
| Homebuilder | XHB | 0.69% | 7.70% | 40.1% | 29.1% |
| Retail | XRT | 1.57% | 5.99% | 30.8% | 24.8% |